Sai Parenteral's

Not Rated
  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE0H9F01037
  • NSEID: SAIPARENT
  • BSEID: 544742
INR
423.75
-0.2 (-0.05%)
BSENSE

Apr 10

BSE+NSE Vol: 5.87 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 9.12% vs 17.66% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 25.48% vs 21.77% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is 18.50% vs 28.14% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is 44.37% vs 56.28% in Mar 2024

Compare Profit and Loss Results of Sai Parenteral's
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
124.00
309.00
-185.00
-59.87%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
124.00
309.00
-185.00
-59.87%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
-23.00
23.00
100.00%
Raw Materials Consumed
73.00
125.00
-52.00
-41.60%
Power & Fuel Cost
2.00
28.00
-26.00
-92.86%
Employee Cost
10.00
97.00
-87.00
-89.69%
Operating Expenses
1.00
43.00
-42.00
-97.67%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
1.00
5.00
-4.00
-80.00%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
4.00
11.00
-7.00
-63.64%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
97.00
316.00
-219.00
-69.30%
Operating Profit (PBDIT) excl Other Income
26.00
-6.00
32.00
533.33%
Other Income
0.00
16.00
-16.00
-100.00%
Operating Profit (PBDIT)
27.00
9.00
18.00
200.00%
Interest
7.00
15.00
-8.00
-53.33%
Profit before Depriciation and Tax
19.00
-5.00
24.00
480.00%
Depreciation
5.00
20.00
-15.00
-75.00%
Profit Before Taxation & Exceptional Items
14.00
-26.00
40.00
153.85%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
14.00
-26.00
40.00
153.85%
Provision for Tax
4.00
-10.00
14.00
140.00%
Profit After Tax
10.00
-15.00
25.00
166.67%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
20.00
-173.00
193.00
111.56%
Profit Available for appropriations
30.00
-189.00
219.00
115.87%
Appropriations
30.00
-189.00
219.00
115.87%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
3.89
-2.49
6.38
256.22%
Profit And Loss - Net Sales
Net Sales 124.27 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 9.12% vs 17.66% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 26.97 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 25.48% vs 21.77% in Mar 2024

Profit And Loss - Interest
Interest 7.31 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 18.50% vs 28.14% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax 10.34 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 44.37% vs 56.28% in Mar 2024